TRIPSITTER CLINIC LTD. ANNOUNCES THE CLOSING OF ASSETS ACQUISITION DEAL WITH RECONCIOUS MEDICAL AND APPOINTMENT OF DR. MARK BRAUNSTEIN AS CHAIRMAN

TripSitter Clinic Ltd. (CSE: KETA | FSE: UY0), further to the press release dated Mar 22, 2022, today announced the closing of the acquisition of assets of Insight Systems, PBC doing business as Reconscious Medical.  The assets of Reconscious Medical will be instrumental in the future growth plans of the Company. 

Reconscious Medical is a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring, and support provided through a proprietary technology platform. Reconscious Medical’s primary focus and service to date has been combining psychedelic treatment with psychotherapy in both high and low doses of ketamine.

Highlights of acquisition of assets and future growth plans:

Dr. Mark Braunstein

Dr. Braunstein is a whole an integrative psychiatrist. He completed his residency in general psychiatry and his fellowship in child and adolescent psychiatry in 1997. Shortly thereafter, he began exploring the use of psychoactive plant-based medicines in the treatment of various psychiatric conditions in both children and adults. With over 22 years of clinical experience, Dr. B has pioneered a new path in psychiatric care that integrates wilderness programming, exercise, diet, spirituality, and natural medicines. All with a focus on psychedelic theory. Dr. B is the medical director for multiple psychedelic mental health clinics. His plant-based dosing protocols have made him a sought-after medical consultant, advisor, and educator. He runs inpatient and outpatient treatment programs focused on wellness. Driven by a passion to educate and elevate humanity to a healthier and happier place, Dr. B is involved in multiple projects focused on expanding access, awareness, research, and safety in the field of psychedelics.

TripSitter Clinic LTD., through its wholly owned subsidiary TripSitter Clinic Corp, is at the forefront of two emerging sectors: telehealth and psychedelic medicine. The Company’s consultative virtual clinic, TripSitter.Clinic, is an internationally recognized SaaS platform that provides care, monitoring, and coaching while connecting patients with licensed physicians in the United States who can evaluate for a prescribed psychedelic treatment program of therapeutic low-dose ketamine medication. TripSitter is not a primary care physician (PCP). TripSitter.Clinic requires prospective patients to provide a diagnosis from their PCP along with other health information to their chosen TripSitter physician during the initial intake process. When a patient is approved for treatment by their physician, TripSitter.Clinic connects the patient with experts who also use the platform to consult and coordinate with the patient and their physician.